Back to Faculty & Staff

Peter Rossi, M.D.

Instructor

Education and Degrees

  • M.D., Wayne State University School of Medicine, 1997
  • B.S., Albion College, 1993

Certification

  • American Board of Radiology, Radiation Oncology, (board eligible)

Training

  • Internship, General Surgery, Naval Medical Center San Diego, 1998
  • Residency, Radiation Oncology, Wake Forest University School of Medicine, 2002-2006

Special Interests

  • Prostate carcinoma
  • Genitourinary and gynecological malignancies
  • Low-dose rate and high-dose rate brachytherapy in treatment of malignancies

Selected Recent Publications

·        Rossi P, Atwood T, Jian-ming Z, Lee WR.  MRSI after treatment for prostate cancer:  Is it worth it?  ASTRO presentation, 2007.

 

·        Rossi P, Papagikos M, Clark P, Lee WR. Pre-Treatment PSA Velocity and Prostate Brachytherapy. Brachytherapy, submitted for publication, April, 2006.

 

·        Rossi P, Papagikos M, Clark P, Lee WR. Pre-Treatment PSA Velocity and Prostate Brachytherapy.  Abstract, Oral presentation, American Brachytherapy Society, May, 2006.

 

·        Rossi P, Clark P, McCullough W, Lee WR.  Percent Positive Biopsies is Associated with Freedom From Biochemical Recurrence Following Low Dose Rate Brachytherapy Alone. Urology, Feburary, 2006.

 

·        Rossi P, Clark P, McCullough W, Lee WR.  Percent Positive Biopsies is Associated with Freedom from Biochemical Recurrence following Low Dose Rate Brachytherapy Alone. Selected for Oral Presentation at ABS annual meeting, June 2005.

 

·        Rossi P, Kearns W, Williams D, Greven KM. Underdosing of the Jugular Foramen in 3-D CT Planning: A dosimetric analysis. Poster Presentation, IJROBP, 2004.

 

·        Rossi P, Shaw EG. Hormone receptor positivity in Pilocytic Astrocytoma. Poster Presentation, Neuro-Oncology 5(4) 2003.

 

·        Papagikos MA, Rossi P, Clark P, Lee WR.  Simple But Robust Model to Predict Outcome Following Brachytherapy for Prostate Cancer.  Brachytherapy (Accepted, August, 2006)

 

·        Powell D, Rossi P, Bourland J, Tatter S, Shaw E.  Stereo tactic Radiosurgery Improves Pre-Treatment Symptoms in Patients with Acoustic Neuroma, ASTRO abstract, 2007.  

 

·        Papagikos MA, Rossi PJ and Lee WR. Publication Rate of Abstracts from the Annual ASTRO Meeting: Common or Uncommon and How Do We Compare? JACR  2(1) 2005.

 

·        Papagikos MA, Rossi PJ, Clark P, Lee WR.  V100 Predicts Freedom From Biochemical Recurrence following Prostate Brachytherapy alone.  IJROBP, Accepted August, 2005.

 

·        Papagikos MA, Rossi PJ, Shaw EG, et al. Results of Stereotactic Radiosurgery and GliaSite Brachytherapy for Recurrent Glioblastoma Multiforme. Abstract RT-08 Neuro-Oncology 5(4) 2003.

 

·        Papagikos MA, Deguzman AF, Rossi PJ, McCullough DL, Clark PE, Lee WR.  Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
Brachytherapy. 2005;4(4):252-8.

 

·        Johnstone PAS, Rossi PJ, Jani AB, Master V.  “’Insignificant’ prostate cancer on biopsy.”  In review, Int J Radiat Oncolo Biol Phys.

 

·        Johnstone PAS, Rossi PJ, Jani AB, Master V.  “’Insignificant’ prostate cancer on biopsy.”  Submitted, 2007 Prostate Cancer Symposium, Orlando, FL, 22-24 February, 2007.